Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-01-11
2005-01-11
Aulakh, Charanjit S. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S087000, C546S086000, C546S085000, C546S152000, C546S171000, C514S311000, C514S312000
Reexamination Certificate
active
06841555
ABSTRACT:
The invention provides novel lavendamycin analogs having the following general formula:and quinoline-5,8-diones having the following formula:Methods of making and using and compositions containing these compounds are also disclosed.
REFERENCES:
patent: 3084165 (1963-04-01), Schellhammer et al.
patent: 5712289 (1998-01-01), Behforouz et al.
patent: 6030983 (2000-02-01), Behforouz et al.
patent: 6444684 (2002-09-01), Behforouz et al.
Liao, T. et al.: Synthetic studies of the antitumor antibiotic streptonigrin. J. Heterocycl. Chem. vol. 13, pp. 1063-1065, 1976.*
Balitz, D.M. et al.: Isolation of lavendamycin. J. Antibiotics, vol. 35, pp. 259-265, 1982.
Behforouz Mohammad
Behforouz Nancy C.
Aulakh Charanjit S.
Ball State University
Brinks Hofer Gilson & Lione
Zayia Gregory H.
LandOfFree
Lavendamycin analogs, quinoline-5,8-diones and methods of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Lavendamycin analogs, quinoline-5,8-diones and methods of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lavendamycin analogs, quinoline-5,8-diones and methods of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3423866